876299-63-7Relevant academic research and scientific papers
Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors
-
Page/Page column 33, (2008/06/13)
A compound of formula (I), or a pharmaceutically acceptable salt and/or solvate (including hydrate) thereof; and the use of a compound of formula (I) in the treatment of a TNF-mediated disease, disorder, or condition, or a p38-mediated disease, disorder, or condition, in particular the allergic and non-allergic airways diseases, more particularly obstructive or inflammatory airways diseases, preferably chronic obstructive pulmonary disease.
